Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2013. Start Trial.
Date Value
October 09, 2026 6.891
October 08, 2026 6.891
October 07, 2026 6.891
October 06, 2026 6.891
October 05, 2026 6.891
October 02, 2026 6.891
October 01, 2026 6.891
September 30, 2026 6.891
September 29, 2026 6.891
September 28, 2026 6.891
September 25, 2026 6.891
September 24, 2026 6.891
September 23, 2026 6.891
September 22, 2026 6.134
September 21, 2026 6.134
September 18, 2026 6.134
September 17, 2026 6.462
September 16, 2026 6.615
September 15, 2026 6.615
September 14, 2026 6.615
September 11, 2026 6.615
September 10, 2026 6.728
September 09, 2026 6.728
September 08, 2026 6.728
September 04, 2026 6.728
Date Value
September 03, 2026 6.728
September 02, 2026 6.728
September 01, 2026 6.728
August 31, 2026 6.728
August 28, 2026 6.728
August 27, 2026 6.728
August 26, 2026 6.728
August 25, 2026 6.728
August 24, 2026 6.728
August 21, 2026 6.728
August 20, 2026 7.049
August 19, 2026 7.049
August 18, 2026 7.049
August 17, 2026 7.049
August 14, 2026 7.049
August 13, 2026 4.959
August 12, 2026 4.959
August 11, 2026 4.959
August 10, 2026 4.959
August 07, 2026 4.959
August 06, 2026 4.959
August 05, 2026 4.959
August 04, 2026 4.959
August 03, 2026 4.959
July 31, 2026 4.959

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Nicox SA --
DBV Technologies SA 2.790
Cellectis SA 3.090
Genfit SA --
Innate Pharma SA --

Price to Book Value Related Metrics

PS Ratio 3.574
PEG Ratio -0.0239
Price 3.37
Earnings Yield -31.06%
Market Cap 639.11M
PEGY Ratio -0.0239